High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Khwaja J, Bomsztyk J, Mahmood S, Wisniowski B, Shah R, Tailor A, Yong K, Popat R, Rabin N, Kyriakou C, Sive J, Esposti SD, Larkin DFP, Worthington S, Hart A, Dowling E, Correia N, Bygrave C, Rydzewski A, Jamroziak K, Wechalekar AD.
Khwaja J, et al. Among authors: sive j.
Blood Cancer J. 2022 Sep 5;12(9):128. doi: 10.1038/s41408-022-00717-2.
Blood Cancer J. 2022.
PMID: 36064540
Free PMC article.
No abstract available.